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first used qRT-PCR analysis to find dysregulated circRNAs in ccRCC. A novel circRNA, hsa_circ_001895, was upregulated in ccRCC specimens and associated with metastatic properties of ccRCC. However, the tumorigenic mechanism of hsa_circ_001895 on ccRCC is yet to be found. We first indicated that hsa_circ_001895 predicted a poor prognosis in ccRCC patients. Additionally, overexpression of hsa_circ_001895 not only promoted cell proliferation, invasion and migration of ccRCC, but also inhibited cell apoptosis, whereas hsa_circ_001895 knockdown reversed the effect on ccRCC progression. In vivo s.c. xenotransplanted tumor model also showed that silencing hsa_circ_001895 could suppress in vivo ccRCC growth. Mechanistically, hsa_ circ_001895 directly binds with microRNA (miR)-296-5p and inhibits its expression.
Moreover, sex determining region Y (SRY)-box 12 (SOX12) was identified as a target of miR-296-5p, the expression of which was suppressed by miR-296-5p. Notably, the inhibitory effect of hsa_circ_001895 on ccRCC progression was reversed by miR-296-5p inhibitor. In general, our findings indicated that hsa_circ_001895 may sponge miR-296-5p and promote SOX12 expression, which is the underlying mechanism of hsa_circ_001895-induced ccRCC progression.
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| INTRODUC TI ON
Renal cell carcinoma accounts for at least 3% of malignant diseases, 1 and ranks the second leading cause of urological malignant neoplasm-related death. 2 Clear cell renal cell carcinoma (ccRCC) comprises 80%-90% of RCC with higher invasive ability and relapse rate than other RCC subtypes. 3 Incidence and mortality of ccRCC appear to be increasing rapidly in the past few decades as a result of this highly metastatic disease. 4 Overall patient survival is not satisfactory as a result of local recurrence and distant metastasis. [5] [6] [7] Therefore, identification of new sensitive biomarkers and investigation of the underlying molecular mechanism would be of great clinical significance for diagnosis and treatment.
Circular RNAs (circRNAs), covalently closed continuous loop without 5′-3′ polarity and polyadenylation tails, 8 are widespread in the cytoplasm. 9 CircRNAs have been found to be dysregulated in cancers. 10 However, the functional role of circRNAs in carcinogenesis is yet to be found. Recently, research has found that circRNAs play an important role in growth and metastasis of various tumors. 11 CircHIAT1 was downregulated in ccRCC, and inhibition of circHIAT1 promoted cell migration and invasion of ccRCC. 12 As a result of the complicated pathogenesis of ccRCC, more circRNAs need to be discovered.
Circular RNAs may function in microRNA (miRNA) binding, protein interaction and regulation of mRNA splicing to mediate cancer progression. 13 CircRNAs contain miRNA-binding sites in their sequences, 14 which enable them to regulate miRNA function as a miRNA sponger. 9 It has been reported that miRNAs usually bind to the 3′ UTR of target mRNAs to regulate gene expression. 15 Therefore, the binding of circRNAs to miRNAs results in the regulation of target gene expression and formation of a circRNA-miRNA-mRNA functional network. For example, circHIAT1 binds to miR-195-5p/29a-3p/29c-3p to upregulate CDC42, thus participating in ccRCC progression. 12 Although multiple circRNAs have been reported to regulate tumor progression, 16 the functional roles of circRNAs in ccRCC remain largely unknown. We found a novel circRNA, hsa_circ_001895, which was upregulated in ccRCC specimens and associated with poor prognosis of ccRCC patients. Hereafter, we investigated the impact of hsa_circ_001895 on tumor progression of ccRCC. Moreover, the downstream target and underlying mechanism were also explored. The results might have certain guiding significance for development of novel ccRCC therapy.
| MATERIAL S AND ME THODS

| Patients and tumor tissue collection
Total of 60 paired ccRCC and adjacent noncancer tissues were collected from patients by surgical resection at Nanfang Hospital, Southern Medical University. The patients were diagnosed by pathology examination. Permission for this study was obtained from the ethics committee of the institution, and all patients signed written informed consent. Patients with ccRCC are assigned as stage I, II, III and IV by TNM classification.
| In situ hybridization
Clear cell renal cell carcinoma tissues of 5-μm thickness at different TNM stages were fixed in 10% formalin, and embedded with paraffin. After dewaxing and rehydration, the sections were digested with 20 µg/mL proteinase K for 30 minutes. Four percent paraformaldehyde-fixed sections were hybridized with 8 ng/µL specific antisense oligonucleotide DNA probe synthesized by Invitrogen overnight at 55°C. The samples were incubated with HRP (Sigma Aldrich) at 4°C for 30 minutes. Hybridization signals were amplified with diaminobenzidine (DAB; Sigma Aldrich), and images were taken by fluorescent microscope (DP12 SZX7; Olympus Inc.).
| Cell culture and transfection
Human ccRCC cell lines (786-O, A498, OS-RC-2, 769-P and ACHN) and human renal proximal tubular epithelial cell line HK2, purchased from Chinese Academy of Sciences, were cultured in RPMI 1640 medium (Lonza) supplemented with 10% FBS (Gibco). Constant temperature of 37°C with 5% CO 2 was used for incubating cells.
For silencing of hsa_circ_001895, shRNA target hsa_circ_001895 or the negative control (shNC) was inserted into pLKO.1 vector (Biosettia). MicroRNA-296-5p mimics, inhibitor and the respective negative controls (miR-NC, inh NC) were synthesized by GenePharma. 786-O or A498 cells were transfected with miR-296-5p mimics/inhibitor (20 nmol/L) or their NC by Lipofectamine 2000.
HEK-293T cells (4 × 10
| Fluorescence in situ hybridization
786-O or A498 cells were first fixed in 4% formaldehyde solution, and then incubated with 0.1% Triton X-100. Fluorescence-conjugated hsa_circ_001895 or miR-296-5p probes (40 nmol/L) (Invitrogen) were hybridized at 37°C with cells in the dark for 5 hours. The cells were then photographed by laser scanning confocal microscopy (Carl Zeiss).
| Cell proliferation assay
786-O or A498 cells were seeded in 96-well plates at a concentration of 2 × 10 3 /well. CCK8 solution (20 μL; Dojindo) was added to each well and mixed for 2 hours. Microplate Autoreader (ThermoFisher) was used to measure absorbance at 450 nm every 24 hours. For colony formation experiments, 786-O or A498 cells were seeded on six-well plates at a concentration of 1 × 10 3 /well with RPMI 1640 medium. Fourteen days later, the colonies were fixed in methanol and stained with crystal violet (0.1%). Visible colonies were counted and photographed under a light microscope (Bx41, Olympus). Immunostaining was visualized and photographed under a fluorescent microscope (Olympus inverted microscope IX71). 
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| Flow cytometer
| Wound healing
786-O or A498 cells were seeded in 24-well plates at a concentration of 1 × 10 6 /well for 24 hours. Wound gaps were then formed by gentle scratching using a plastic pipette tip in the cell monolayer of each well. Debris or detached cells were removed and cultured in DMEM for another 24 hours before calculating wound width under an inverted microscope (CKX53, Olympus). 
| Transwell assay
| Dual luciferase reporter assay
Wild-type or mutant hsa_circ_001895 or 3′-UTR SOX12 was synthesized and then subcloned into pmirGLO (Promega). miR-296-5p, miR-520h or miR-516a-5p containing the binding sites of hsa_circ_001895 were also subcloned into pmirGLO luciferase reporter vector. Additionally, 3′-UTR nuclear factor I-C (NFIC), RNF44 (ring finger protein 44) and SOX12 were also subcloned into pmirGLO luciferase reporter vector. 786-O or A498 cells were seeded in 24-well plates at a concentration of 3 × 10 4 per well and cotransfected miR-296-5p mimics or miR-NC with pmirGLO-wt-hsa_circ_001895, pmirGLO-mut-hsa_circ_001895, pmirGLO-wt-SOX12 or pmirGLO-mut-SOX12. HEK293 cells were also transfected with pmirGLO-miR-296-5p, miR-520h, miR-516a-5p, NFIC, RNF44 or SOX12. Two days later, luciferase activities were measured by Lucifer Reporter Assay System (Promega) and normalized to Renilla luciferase activity.
| RNA immunoprecipitation
786-O or A498 cells were collected and lysed using Magna
RIP Kit (EMD Millipore), and then incubated with protein G Sepharose beads (GE Healthcare) coated with anti-AGO2 antibody (Abcam) at 4°C overnight, and anti-IgG antibody was used as the negative control. RNA was then isolated for qRT-PCR as mentioned below. 
TA B L E 1 Primer sequences used for qRT-PCR
ID Sequence (5′-3′) GAPDH F ACCACAGTCCATGCCATCAC GAPDH R TCCACCACCCTGTTGCTGTA β-actin F GGGCATCCTGACCCTCAAG β-actin R TCCATGTCGTCCCAGTTGGT U2 F CGAAGGTTCAGGTTTACTCACG U2 R ATTTCAATCTCAGGCGGA hsa_circ_001895 F TGGAGACTGGGGGAAGATGA hsa_circ_001895 R CACACTAACTGGCTGAGGGG CTBP1 F GTGCCCTGATGTACCATACCA CTBP1 R GCCAATTCGGACGATGATTCTA miR-516a-5p F CGGCGGATCACACAAAGGCAA miR-516a-5p R CGGCGGGAGTGCCTTCTTTTG miR-520h F TCGCGACAAAGTGCTTCCCT miR-520h R GTGCAGGGTCCGAGGT miR-296-5p F CGTCTATACAGACCCTGGCTTTTC miR-296-5p R CTCAACTGGTGTCGTGGA NFIC F GGACAGGGATGGGCTCTG NFIC R CGTTCTTCTGAGGCCAGTGC RNF44 F CCTACTTCCTCTCGATGCTG RNF44 R CTGCTCTATGTCTGCTTTGG SOX12 F CGCGATGGTGCAGCAGCG SOX12 R GCCACTGGTCCATGATCTTC U6 F CTCGCTTCGGCAGCACA U6 R AACGCTTCACGAATTTGCGT
| qRT-PCR
| Western blot
| Mouse xenograft assay
| Hematoxylin and eosin staining
Clear cell renal cell carcinoma tissues from mice were fixed in 4% 
| Immunohistochemistry
| Statistical analysis
All results are expressed as mean ± SEM. We determined the statistical analyses using GraphPad Prism software and one-way analysis of variance (ANOVA). Overall survival difference between patients with high or low levels of hsa_circ_001895 expression was analyzed by Kaplan-Meier method and log-rank test. P < .05, P < .01 or P < .001 were considered statistically significant.
| RE SULTS
| CircRNA hsa_circ_001895 was upregulated in both ccRCC tissues and cell lines
We first screened three paired ccRCC and adjacent noncancer tissues by qRT-PCR. Hierarchical clustering indicated 12 upregulated and four downregulated circRNAs in ccRCC tissues ( Figure 1A) . A new circRNA hsa_circ_001895 was verified to be upregulated in ccRCC tissues ( Figure 1B) . Moreover, qRT-PCR also showed upregulation of hsa_circ_001895 in 60 pairs of ccRCC tissues compared to adjacent noncancer tissues ( Figure 1B ). Additionally, hsa_circ_001895 was positively related to TNM stage of ccRCC by in situ hybridization (ISH; Figure 1C ), suggesting that hsa_circ_001895 may contribute to the progression of ccRCC.
Depending on median ratio of hsa_circ_001895 expression, patients were divided into a high hsa_circ_001895 expression group (N = 30) and a low hsa_circ_001895 expression group (N = 30).
Kaplan-Meier survival analysis showed that high expression of hsa_ circ_001895 showed shorter overall survival (OS) than patients with low expression of hsa_circ_001895 (P = .0406; Figure 1D ). Further refinement analysis of correlation between hsa_circ_001895 expression and clinicopathological characteristics of ccRCC patients showed that among the 60 patients, high expression of hsa_ circ_001895 was significantly related to TNM stage (P = .005), pT stage (P = .003) and pN stage (P = .001; Table 2 ). Moreover, other clinical characteristics such as age (P = .605), gender (P = .787), and so on, showed no significant correlation with hsa_circ_001895 expression ( Table 2 ). These results indicated that upregulation of hsa_circ_001895 was related to poor prognosis of ccRCC, suggesting a potential prognostic biomarker of hsa_circ_001895 in ccRCC.
Meanwhile, the expression of hsa_circ_001895 was also upregulated in five human ccRCC cell lines (786-O, A498, OS-RC-2, 769-P and ACHN) compared to HK2 ( Figure 1E ). 786-O and A498 cells with higher expression of hsa_circ_001895 were chosen for subsequent functional assays. RNase R that could digest linear RNAs was used to further verify the circular nature of hsa_circ_001895, and the result indicated that hsa_circ_001895 was resistant to RNase R digestion compared to linear CTBP1 ( Figure 1F ).
| Hsa_circ_001895 promoted ccRCC proliferation
Results of nuclear and cytoplasmic separation experiments showed that hsa_circ_001895 was mainly located in the cytoplasm (Figure 2A ). FISH also confirmed the cytoplasm localization of hsa_circ_001895 in ccRCC cells ( Figure 2B ). The specific mechanism of hsa_circ_001895 involved in ccRCC was further investigated through gain-and loss-of-function assays. First, 786-O and A498 cells transfected with sh-hsa_circ_001895 or pcDNA-hsa_circ_001895 for the knockdown or overexpression of hsa_circ_001895, respectively, were determined by qRT-PCR as shown in Figure 2C . Knockdown or overexpression of hsa_circ_001895 and CTBP1 were not influenced by each other ( Figure 2C ). Second, CCK-8 ( Figure 2D ) showed that sh-hsa_circ_001895 decreased cell viability of ccRCC cells, whereas pcDNA-hsa_circ_001895 increased cell viability.
Moreover, colony formation ( Figure 2E ) and EdU labeling ( Figure 2F ) assays showed the promotion ability of hsa_circ_001895 overexpression on cell proliferation of ccRCC cells. However, hsa_circ_001895 knockdown showed the reverse effect on cell proliferation (Figure 2E,F) . Last, flow cytometry indicated that hsa_circ_001895 knockdown blocked the cell cycle at G1 phase, whereas hsa_circ_001895 overexpression promoted the cell cycle ( Figure 2G ).
| Hsa_circ_001895 promoted ccRCC migration and invasion and inhibited cell apoptosis
Wound-healing assay indicated the suppression ability of hsa_ circ_001895 knockdown on cell migration ( Figure 3A ). However, hsa_circ_001895 overexpression promoted cell migration ( Figure 3A) .
Moreover, the suppression ability of hsa_circ_001895 knockdown or the promotion ability of hsa_circ_001895 overexpression on cell invasion ( Figure 3B ) was also confirmed by Transwell assay. Flow cytometry showed that hsa_circ_001895 could suppress cell apoptosis, whereas hsa_circ_001895 knockdown induced cell apoptosis ( Figure 3C ). As proteins involved in cell migration and invasion, E-cadherin was increased and N-cadherin was decreased by hsa_circ_001895 knockdown ( Figure 3D ). Moreover, as proteins involved in cell apoptosis, Bcl-2 was decreased whereas Bax and Cleaved caspase 3 were increased by hsa_circ_001895 knockdown (Figure 3D) . Similarly, hsa_circ_001895
overexpression showed the reverse effect on protein expression in ccRCC cells ( Figure 3D ), confirming that hsa_circ_001895 may account for the malignant phenotypes of ccRCC.
| Negative correlation between hsa_ circ_001895 and miR-296-5p
The potential binding targets of hsa_circ_001895 were predicted as miR-296-5p, miR-520h and miR-516a-5p through CircInteractome (circRNA interactome) and starBase ( Figure 4A ). Dual luciferase reporter assay indicated the highest relative intensity of miR-516a-5p, and higher relative intensity of miR-520h than miR-296-5p in HEK293 cells ( Figure 4B ).
miR-296-5p was upregulated in 786-O and A498 cells transfected with
sh-hsa_circ_001895, whereas miR-516a-5p and miR-520h were not affected by hsa_circ_001895 knockdown ( Figure 4C ). Moreover, FISH showed colocalization of hsa_circ_001895 and miR-296-5p in the cytoplasm ( Figure 4D ). To further determine the binding ability between hsa_circ_001895 and miR-296-5p, dual luciferase reporter assay was conducted ( Figure 4E ). Results showed that miR-296-5p mimics decreased the luciferase activity of pmirGLO-wt-hsa_circ_001895, but had no effect on luciferase activity of pmirGLO-mut-hsa_circ_001895
( Figure 4F ). RNA immunoprecipitation (RIP) assay showed that both Figure 4G) . Moreover, miR-296-5p was downregulated in ccRCC tissues ( Figure 4H ), and bivariate correlation analysis showed negative correlation between miR-296-5p and hsa_circ_001895 in ccRCC ( Figure 4I ). Collectively, these results indicated that hsa_circ_001895 could directly bind to miR-296-5p and inhibit its expression.
| SOX12 was a direct target of miR-296-5p
Similarly, SOX12, NFIC and RNF44 were predicted as miR-296-5p binding targets through TargetScan, miRDB, miRTarBase, miRWalk and miRTargetLink Human ( Figure 5A ). Dual luciferase reporter assay indicated the highest relative intensity of RNF44, and higher relative intensity of SOX12 than NFIC in HEK293 cells ( Figure 5B ). Both mRNA ( Figure 5C ) and protein ( Figure 5D ) expression of NFIC and SOX12 were downregulated in cells transfected with sh-hsa_circ_001895, whereas RNF44 was not affected by hsa_circ_001895 knockdown (Figure 5C,D) .
Dual luciferase reporter assay was also conducted ( Figure 5E) , and results showed that miR-296-5p mimics decreased the luciferase activity of pmirGLO-wt-SOX12, but had no effect on luciferase activity of pmirGLO-mut-SOX12 ( Figure 5F ). Transfection efficiency of miR-296-5p mimics or inhibitor were confirmed by qRT-PCR ( Figure 5G) . Moreover, the expression of SOX12 was decreased by miR-296-5p mimics but increased by miR-296-5p inhibitor ( Figure 5H ). Upregulation of SOX12 in ccRCC tissues was confirmed by qRT-PCR ( Figure 5I) . Moreover, the expression of SOX12 was positively related to the TNM stage of ccRCC by ISH ( Figure 5J ). Therefore, expression of SOX12 was significantly negatively correlated with miR-296-5p, but positively correlated with hsa_ circ_001895 in ccRCC ( Figure 5K ). The upregulation of SOX12 was also confirmed by western blot (Figure 5L ). Collectively, these results showed that miR-296-5p could directly bind to SOX12 and inhibit its expression.
| Hsa_circ_001895 knockdown inhibited ccRCC proliferation by sponging miR-296-5p
Clear cell renal cell carcinoma cells were cotransfected with sh-hsa_circ_001895 and miR-296-5p inhibitor. First, CCK-8 ( Figure 6A) showed that that the inhibition of cell viability by sh-hsa_circ_001895 was promoted by additional transfection with miR-296-5p inhibitor.
miR-296-5p inhibitor reversed the inhibition ability on cell proliferation by colony formation ( Figure 6B ) and EdU staining ( Figure 6C) assays.
Moreover, cell cycle blocked by hsa_circ_001895 knockdown was promoted by additional transfection with miR-296-5p inhibitor ( Figure 6D ). Together, these results further suggested that hsa_circ_001895 knockdown inhibited ccRCC proliferation by sponging miR-296-5p.
| Hsa_circ_001895 knockdown inhibited ccRCC migration and invasion but induced cell apoptosis by sponging miR-296-5p
Migration ( Figure 7A ) and invasion ( Figure 7B Figure 7D ).
| Hsa_circ_001895 knockdown inhibited in vivo ccRCC tumor
We inoculated 786-O cells transfected with sh-hsa_circ_001895 or sh-NC into nude mice to explore the clinical application of The present study showed that hsa_circ_001895 might be a potential novel target for ccRCC therapy. As the "oncogene" function of hsa_circ_001895 in ccRCC was found, we then determined the underlying mechanism. First, the Generally, circRNAs regulate gene expression by sponging miRNAs. 30 By the means of dual luciferase reporter assay and RIP, miR-296-5p was validated as the direct binding target for hsa_circ_001895. miR-296-5p is a tumor suppressor in various tumors. [31] [32] [33] The present study indicated that hsa_circ_001895 knockdown inhibited ccRCC progression but induced cell apoptosis through sponging miR-296-5p. It is the first time that miR-296-5p is associated with ccRCC progression. As is well known, von Hippel-Lindau tumor-suppressor gene (VHL), a powerful suppressor of ccRCC, is mutated in most ccRCC cell lines, including 786-O. 34 VHL-mediated miRNAs might be involved in regulation of renal cancer progression. 35 miRNAs could target VHL-hypoxiainducible factor 1-alpha pathway to predict renal cell carcinoma risk. 36 Whether the circ_001895-miR-296-5p axis participates in VHL-mediated ccRCC progression needs to be further studied.
| D ISCUSS I ON
Moreover, SOX12 was identified as a target of miR-296-5p. SOX proteins contain a conserved DNA-binding domain to participate in numerous important biological processes, such as cell differentiation during embryonic development. 37 Aberrant embryonic development has been considered to be associated with cancer development. 38 Moreover, EMT has also been involved in embryonic development during cancer development. Therefore, SOX12 may be associated with EMT during ccRCC progression. 39 SOX12 was found to promote hepatocellular carcinoma metastasis 40 or inhibit colon cancer metastasis 41 by different signaling pathways. More recently, SOX12 was shown to be a predictive marker of prognosis in ccRCC patients. 42 Our study showed that hsa_circ_001895 knockdown suppressed xenograft ccRCC tumor growth by SOX12, further confirming the important regulatory ability of SOX12 on ccRCC progression. However, the underlying signaling pathway involved in the regulation of SOX12 on ccRCC progression needs to be further investigated.
Generally, our results showed that hsa_circ_001895 is an "oncogene," the knockdown of which inhibited ccRCC progression and promoted cell apoptosis through miR-296-5p-mediated SOX12.
Relationship between the hsa_circ_001895/miR-296-5p/SOX12 regulatory axis and ccRCC progression suggests the potential application of hsa_circ_001895 in ccRCC.
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